Orticumab (Anti-oxLDL)
Product Specifications
CAS Number
1314241-10-5
Synonyms
MLDL1278A
Target
LDL
Applications
Metabolism
Additionnal Information
Orticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL) . Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
JEL1002 100 mL
Cell Culture Grade Biomaterial. 100mL Liquid Collagen for Research and In-Vitro Use Only. Concentation = 4mg/mL Providing 400mg of Collagen - 100ML
Sign In for Pricing
View Details 
MBS1396197-01 0.02 mg (E-Coli)
Recombinant Aeropyrum pernix Probable RNA 2'-phosphotransferase (kptA)
Sign In for Pricing
View Details MBS1396197-02 0.1 mg (E-Coli)
Recombinant Aeropyrum pernix Probable RNA 2'-phosphotransferase (kptA)
Sign In for Pricing
View Details MBS1396197-03 0.02 mg (Baculovirus)
Recombinant Aeropyrum pernix Probable RNA 2'-phosphotransferase (kptA)
Sign In for Pricing
View Details MBS1396197-04 0.02 mg (Mammalian-Cell)
Recombinant Aeropyrum pernix Probable RNA 2'-phosphotransferase (kptA)
Sign In for Pricing
View Details MBS1396197-05 1 mg (E-Coli)
Recombinant Aeropyrum pernix Probable RNA 2'-phosphotransferase (kptA)
Sign In for Pricing
View Details